Clinical trials
Hemorrhagic Fever, Ebola trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 8 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Terminated | 5 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 13 |
| Janssen Vaccines & Prevention B.V. | 4 |
| Arbutus Biopharma Corporation | 2 |
| Sarepta Therapeutics, Inc. | 2 |
| Albert B. Sabin Vaccine Institute | 1 |
| Auro Vaccines LLC | 1 |
| Cerus Corporation | 1 |
| Crucell Holland BV | 1 |
| Emory University | 1 |
| Inovio Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhagic Fever, Ebola | 28 |
| Hemorrhagic Fevers, Viral | 7 |
| Marburg Virus Disease | 3 |
| Virus Diseases | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Angioedemas, Hereditary | 1 |
| Communicable Diseases | 1 |
| Creutzfeldt-Jakob Syndrome | 1 |
| Disseminated Intravascular Coagulation | 1 |
| Filoviridae Infections | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.